001027030 001__ 1027030
001027030 005__ 20251010111343.0
001027030 0247_ $$2doi$$a10.2214/AJR.23.30612
001027030 0247_ $$2ISSN$$a0002-9580
001027030 0247_ $$2ISSN$$a0361-803X
001027030 0247_ $$2ISSN$$a0092-5381
001027030 0247_ $$2ISSN$$a0092-5632
001027030 0247_ $$2ISSN$$a1546-3141
001027030 0247_ $$2ISSN$$a2769-8785
001027030 037__ $$aFZJ-2024-03596
001027030 082__ $$a610
001027030 1001_ $$0P:(DE-HGF)0$$aHu, Leland S.$$b0$$eCorresponding author
001027030 245__ $$aAdvanced Imaging in the Diagnosis and Response Assessment of High-Grade Glioma: AJR Expert Panel Narrative Review
001027030 260__ $$aLeesburg, Va.$$bAmerican Roentgen Ray Society$$c2025
001027030 3367_ $$2DRIVER$$aarticle
001027030 3367_ $$2DataCite$$aOutput Types/Journal article
001027030 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1760087190_3589
001027030 3367_ $$2BibTeX$$aARTICLE
001027030 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001027030 3367_ $$00$$2EndNote$$aJournal Article
001027030 500__ $$aSupported by NIH grants to L. S. Hu (nos.U01CA220378, U01CA250481,R01CA264992, R01CA221938, and R21NS082609).
001027030 520__ $$aThis AJR Expert Panel Narrative Review explores the current status of advanced MRI and PET techniques for the posttherapeutic response assessment of high-grade adult-type gliomas, focusing on ongoing clinical controversies in current practice. Discussed techniques that complement conventional MRI and aid the differentiation of recurrent tumor from posttreatment effects include DWI and diffusion-tensor imaging; perfusion MRI techniques including dynamic susceptibility contrast (DSC), dynamic contrast-enhanced, and arterial spin labeling MRI; MR spectroscopy (MRS) including assessment of 2-hydroxyglutarate (2HG) concentration; glucose- and amino acid (AA)-based PET; and amide proton transfer imaging. Updated criteria for the Response Assessment in Neuro-Oncology are presented. Given the abundant supporting clinical evidence, the panel supports a recommendation that routine response assessment after high-grade glioma treatment should include perfusion MRI, particularly given the development of a consensus recommended DSC-MRI protocol. Although published studies support 2HG MRS and AA PET, these techniques' widespread adoption will likely require increased availability (for 2HG MRS) or increased insurance funding in the United States (for AA PET). The review concludes with a series of consensus opinions from the author panel, centered on the clinical integration of the advanced imaging techniques into posttreatment surveillance protocols.Keywords: PET; advanced MRI; high-grade glioma; posttreatment; surveillance. 
001027030 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001027030 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001027030 7001_ $$0P:(DE-HGF)0$$aSmits, Marion$$b1
001027030 7001_ $$0P:(DE-HGF)0$$aKaufmann, Timothy J.$$b2
001027030 7001_ $$0P:(DE-HGF)0$$aKnutsson, Linda$$b3
001027030 7001_ $$0P:(DE-HGF)0$$aRapalino, Otto$$b4
001027030 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b5
001027030 7001_ $$0P:(DE-HGF)0$$aSundgrene, Pia C.$$b6
001027030 7001_ $$0P:(DE-HGF)0$$aCha, Soonmee$$b7
001027030 773__ $$0PERI:(DE-600)2012224-X$$a10.2214/AJR.23.30612$$gp. AJR.23.30612$$n1$$pAJR.23.30612$$tAmerican journal of roentgenology$$v224$$x0002-9580$$y2025
001027030 8564_ $$uhttps://juser.fz-juelich.de/record/1027030/files/PDF.pdf$$yRestricted
001027030 8564_ $$uhttps://juser.fz-juelich.de/record/1027030/files/post-print.pdf$$yRestricted
001027030 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b5$$kFZJ
001027030 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001027030 9141_ $$y2025
001027030 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J ROENTGENOL : 2022$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bAM J ROENTGENOL : 2022$$d2024-02-05
001027030 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J ROENTGENOL : 2022$$d2024-12-20
001027030 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bAM J ROENTGENOL : 2022$$d2024-12-20
001027030 920__ $$lyes
001027030 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001027030 980__ $$ajournal
001027030 980__ $$aEDITORS
001027030 980__ $$aVDBINPRINT
001027030 980__ $$aI:(DE-Juel1)INM-3-20090406
001027030 980__ $$aUNRESTRICTED